On July 15, ByteDance and Alibaba removed their user-defined AI agent features from their chatbots Doubao and Qwen. The move is widely seen as a proactive compliance response to eliminate regulatory risk as user-created AI agents, which are large in number and fragmented in styles and functions, are difficult to review and continuously monitor.
Investors have cooled on China’s biotechnology sector, after a spectacular run-up in Hong Kong biotech stocks in early 2025. This is a needed correction: China’s biotech companies are technologically strong, but commercially immature. Also in today’s China Tech Brief: drones and EVs.